close 73% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 73% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

Strona główna・Stock List・Karyopharm Therapeutics Inc
Search

Karyopharm Therapeutics Inc

Closed

SectorHealthcare

6.73 -0.88

Strong Buy

Price update 15 gru 2025, 20:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

6.51

Max

6.86

Key metrics

By Trading Economics

Income

4.1M

-33M

Sales

6.1M

44M

EPS

-3.82

Profit margin

-75.213

Employees

279

EBITDA

1.8M

-23M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+98.99% upside

Market Stats

By TradingEconomics

Market Cap

-1.8M

100M

Previous open

7.61

Previous close

6.73

News Sentiment

By Acuity

50%

50%

165 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

5.9501 / 7.66 Support & Resistance

Karyopharm Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

15 gru 2025, 17:39 UTC

Major Market Movers

Vanda Pharmaceuticals Rises on FDA Biologics License Application

DJ

Read

15 gru 2025, 23:44 UTC

Market Talk

Gold Steady Ahead of U.S. Employment Report -- Market Talk

DJ

Read

15 gru 2025, 23:38 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Read

15 gru 2025, 23:38 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Decline -- Market Talk

DJ

Read

15 gru 2025, 22:19 UTC

Market Talk

Clean-Energy Project Developers Benefit From 'Deep Buyer Universe' -- Market Talk

DJ

Read

15 gru 2025, 21:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

DJ

Read

15 gru 2025, 21:42 UTC

Acquisitions, Mergers, Takeovers

Comcast Spinoff Versant Debuts at Modest Valuation, a Signal for a Warner Bros. Sale -- Barrons.com

DJ

Read

15 gru 2025, 21:32 UTC

Acquisitions, Mergers, Takeovers

Comcast Spinoff Versant Debuts at Modest Valuation, Puts Warner Bros. Discovery in Focus -- Barrons.com

DJ

Read

15 gru 2025, 21:28 UTC

Acquisitions, Mergers, Takeovers

iRobot Files for Bankruptcy After Amazon Was Forced to Scrap Its Deal to Buy the Roomba Maker -- Barrons.com

DJ

Read

15 gru 2025, 21:26 UTC

Acquisitions, Mergers, Takeovers

Commercial Metals Completes Acquisition of Foley Products for $1.84B >CMC

DJ

Read

15 gru 2025, 21:23 UTC

Acquisitions, Mergers, Takeovers

Perseus Mining: Reserves Right to Make Further Proposal If Circumstances Change

DJ

Read

15 gru 2025, 21:23 UTC

Acquisitions, Mergers, Takeovers

Perseus Mining: Does Not Intend to Submit Revised Takeover Proposal For Predictive

DJ

Read

15 gru 2025, 21:23 UTC

Acquisitions, Mergers, Takeovers

Perseus Mining: Notes Predictive Shares Trade at Discount to Value Implied By Perseus Proposal

DJ

Read

15 gru 2025, 21:22 UTC

Acquisitions, Mergers, Takeovers

Perseus Mining: Believes Revised Robex Merger Inferior to Its Own Takeover Proposal

DJ

Read

15 gru 2025, 21:20 UTC

Acquisitions, Mergers, Takeovers

Commercial Metals Completes Acquisition Of Foley Products Company >CMC

DJ

Read

15 gru 2025, 21:15 UTC

Acquisitions, Mergers, Takeovers

ServiceNow Completes Acquisition Of Moveworks >NOW

DJ

Read

15 gru 2025, 21:00 UTC

Acquisitions, Mergers, Takeovers

Comcast Spinoff Versant Debuts at Low Valuation; Could Figure in Warner Bros. Discovery Takeover Battle -- Barrons.com

DJ

Read

15 gru 2025, 20:57 UTC

Acquisitions, Mergers, Takeovers

Comcast Spinoff Versant Debuts at Low Valuation; Could Figure in Warner Bros. Discovery Takeover Battle -- Barrons.com

DJ

Read

15 gru 2025, 20:36 UTC

Market Talk

Oil Futures Fall Further on Oversupply Concerns -- Market Talk

DJ

Read

15 gru 2025, 20:31 UTC

Market Talk

U.S. Natural Gas Futures Extend Losing Streak -- Market Talk

DJ

Read

15 gru 2025, 20:27 UTC

Market Talk
Acquisitions, Mergers, Takeovers

ServiceNow's Acquisition Streak Could Cause Investor Angst -- Market Talk

DJ

Read

15 gru 2025, 20:15 UTC

Market Talk

El Buen Fin Helps Lift Mexican November Retail Sales -- Market Talk

DJ

Read

15 gru 2025, 19:22 UTC

Market Talk

Gold and Silver Gain to Start Week -- Market Talk

DJ

Read

15 gru 2025, 18:37 UTC

Market Talk

Oil Futures Extend Losses On Oversupply Worries -- Market Talk

DJ

Read

15 gru 2025, 18:29 UTC

Market Talk

ServiceNow Seen Facing Pressure if Government Budgets Decline -- Market Talk

DJ

Read

15 gru 2025, 17:58 UTC

Market Talk

Canada Housing Market In Search Of a Bottom -- Market Talk

DJ

Read

15 gru 2025, 17:36 UTC

Market Talk

Canada Data Signal Underlying Price Pressures Persist -- Market Talk

DJ

Read

15 gru 2025, 17:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Read

15 gru 2025, 17:36 UTC

Earnings

Texas Instruments Stock Slips. It Caught a Rare Downgrade From Goldman Sachs. -- Barrons.com

DJ

Read

15 gru 2025, 17:30 UTC

Acquisitions, Mergers, Takeovers

Cinemark Stock Could Fall Even More If Netflix Buys Warner Bros., Analyst Says -- Barrons.com

DJ

Read

Peer Comparison

Price change

Karyopharm Therapeutics Inc Forecast

Price Target

By TipRanks

98.99% upside

12 Months Forecast

Average 13.83 USD  98.99%

High 21 USD

Low 6 USD

Based on 6 Wall Street analysts offering 12 month price targets forKaryopharm Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

5

Buy

1

Hold

0

Sell

Based on 6 analysts giving stock ratings to Karyopharm Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

5.9501 / 7.66Support & Resistance

Short Term

Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Strong Bearish Evidence

All events are bearish.

Long Term

No Evidence

There are no events.

Sentiment

By Acuity

165 / 374 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

1,061.04

↑ +3.27%

JNJ

Johnson and Johnson

214.42

↑ +1.41%

ABBV

AbbVie Inc

227.63

↑ +1.87%

UNH

UnitedHealth Group Inc

341.44

↑ +0.01%

AZN

AstraZeneca PLC ADR

91.59

↑ +2%
help-icon Live chat